| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |